Specifically, in HCC, serum levels of IGF-1 are diminished and it has been associated with poor prognosis [30, 31], but the patients with the highest levels of IGF previously to antiangiogenic treatment are associated with a better disease control rate [31]. This evidence concerns the gene IGF1 and hepatocellular carcinoma.